WHO Regional Office for Africa

WHO Regional Office for Africa

The World Health Organization has reiterated its commitment to helping the Government of Ghana achieve its set target for the COVID-19 vaccine rollout by presenting 1,000 pieces of digital tablets to support the ongoing vaccination campaign.

Presenting the items to the Ghana Health Service, Dr Sally-Ann Ohene, Disease Prevention and Control Officer at the World Health Organization Ghana Country Office said the tablets were to be used to scale up e-registration at the various vaccination centres and help reduce delays in data entry. 

“With funding support from the Government of Canada, WHO Ghana plans to present additional 500 digital tablets to the Ghana Health Service”, Dr Ohene hinted. 
The Programme Manager for the Expanded Programme on Immunization (EPI) at the Ghana Health Service, Dr Kwame Amponsa-Achiano, who received the items on behalf of the Ghana Health Service, expressed appreciation to the kind gesture.

Dr Amponsa-Achiano stated that the donation of the tablets was very timely and would be deployed immediately to the field for use in the ongoing vaccination campaign. The digital tablets are anticipated to be useful for data capturing in other health interventions beyond the COVID-19 pandemic.

Distributed by APO Group on behalf of WHO Regional Office for Africa.

Send us your press releases to pressrelease.zawya@refinitiv.com

© Press Release 2021

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.